Vicus Capital Pfizer Inc Transaction History

Vicus Capital

$1.09 Billion
Q1 2024

A detailed history of Vicus Capital transactions in Pfizer Inc stock. As of the latest transaction made, Vicus Capital holds 8,467 shares of PFE stock, worth $236,483. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,467

Previous 8,877 4.62%

Holding current value

$236,483

Previous $255,000 8.24%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $10,614 - $12,189	-410 Reduced 4.62%	8,467 $234,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $129,082 - $167,663	-4,940 Reduced 35.75%	8,877 $255,000
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $33,341 - $38,972	1,039 Added 8.13%	13,817 $458,000
Q2 2023 Aug 17, 2023	SELL	$36.12 - $41.79 $42,152 - $48,768	-1,167 Reduced 8.37%	12,778 $468,000
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $5,711 - $7,435	-145 Reduced 1.03%	13,945 $568,000

Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $91,599 - $119,573	-2,194 Reduced 13.47%	14,090 $722,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $38,290 - $46,742	-875 Reduced 5.1%	16,284 $713,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $21,217 - $25,157	456 Added 2.73%	17,159 $900,000
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $63,592 - $78,799	-1,390 Reduced 7.68%	16,703 $865,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $747,602 - $1.11 Million	18,093 New	18,093 $956,000
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $894,123 - $1.01 Million	-24,899 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $157,235 - $177,330	-4,695 Reduced 15.86%	24,899 $902,000
Q4 2020 Feb 01, 2021	SELL	$33.47 - $42.56 $40,164 - $51,072	-1,200 Reduced 3.9%	29,594 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $91,535 - $107,391	-2,883 Reduced 8.56%	30,794 $1.13 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $34,005 - $41,253	1,129 Added 3.47%	33,677 $1.1 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $7,946 - $11,354	294 Added 0.91%	32,548 $1.06 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $36,376 - $41,282	-1,105 Reduced 3.31%	32,254 $1.26 Million
Q3 2019 Nov 18, 2019	SELL	$32.49 - $42.13 $85,091 - $110,338	-2,619 Reduced 7.28%	33,359 $1.2 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $99,180 - $111,356	-2,682 Reduced 6.94%	35,978 $1.56 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $114,375 - $125,660	-3,050 Reduced 7.31%	38,660 $1.64 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $21,697 - $24,737	-564 Reduced 1.33%	41,710 $1.82 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $47,568 - $57,697	1,380 Added 3.37%	42,274 $1.86 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $238,643 - $254,417	7,236 Added 21.5%	40,894 $1.48 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $324,907 - $376,937	10,182 Added 43.37%	33,658 $1.2 Million
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $169,559 - $179,908	5,098 Added 27.74%	23,476 $850,000
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $569,718 - $627,608	18,378	18,378 $656,000

Others Institutions Holding PFE

# of Institutions

3,162

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.

Account